Skip to main content

Division of Hematology and Oncology Archives

Molecular testing across tumor types

Apr. 25, 2022—The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

Read more


Biltibo receives career development award to support hematology research

Apr. 21, 2022—Vanderbilt's Eden Biltibo, MD, a clinical fellow in the Division of Hematology and Oncology, has been selected for the 2022 ASH-CIBMTR-ASTCT Career Development Award.

Read more


Berlin named interim leader of Hematology and Oncology

Mar. 24, 2022—Jordan Berlin, MD, has been appointed interim leader of Vanderbilt's Division of Hematology and Oncology in the Department of Medicine.

Read more


Park named director of Vanderbilt-Ingram Cancer Center

Feb. 17, 2022—Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director.

Read more


Grant to support Haake’s research on kidney cancer

Feb. 17, 2022—Kure It Cancer Research has awarded a $200,000 grant to support kidney cancer research by Vanderbilt's Scott Haake, MD.

Read more


Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

Dec. 24, 2021—New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death.

Read more


New Clinician Spotlight: Katherine Walsh

Dec. 21, 2021—Katherine Walsh, MD, has joined Vanderbilt University Medical Center as associate professor of Medicine in the Division of Hematology and Oncology.

Read more


Cell signaling targets in leukemia

Dec. 9, 2021—Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments.

Read more


Shifts in neuroendocrine cancer clinical trial design

Nov. 2, 2021—Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.

Read more


Park named to new role as deputy director of Vanderbilt-Ingram Cancer Center

Aug. 19, 2021—Ben Ho Park, MD, PhD, Cornelius Abernathy Professor of Medicine, has been named deputy director of Vanderbilt-Ingram Cancer Center (VICC).

Read more


New Clinician Spotlight: Sonya Reid

Aug. 5, 2021—Sonya Reid, MD, MPH, assistant professor of Medicine in the Division of Hematology Oncology, is a member of the Vanderbilt-Ingram Cancer Center Breast Cancer Research Program and sees patients at Vanderbilt Health One Hundred Oaks.

Read more


Clinical trial to test immunotherapy for rectal cancer

Aug. 5, 2021—A new clinical trial seeks to determine whether immunotherapy in combination with short-course radiation followed by surgical resection could be a curative treatment for locally advanced rectal cancer.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more